Diet, menopause and the risk of ovarian, endometrial and breast cancer

Abstract

Menopause, the permanent cessation of the menstrual cycle, marks the end of a woman's reproductive lifespan. In addition to changes in sex hormone levels associated with menopause, its timing is another predictor of future health outcomes such as duration of the presence of vasomotor symptoms (VMS) and the risk of hormone-related cancers. With ageing of the population, it is estimated that worldwide 1·2 billion women will be menopausal by the year 2030. Previously the effects of reproductive factors (e.g. parity, age at menarche, pregnancy) and socio-demographic factors on intermediate and long-term health outcomes of menopause have been widely documented. However, little is known about whether diet could have an impact on these. Therefore, we review current evidence on the associations of diet with menopause, presence of VMS and the risk of hormone-related cancers such as ovarian, endometrial and breast cancer. Dietary factors could influence the lifespan of the ovaries and sex-hormones levels, hence the timing of natural menopause. Few studies reported an association between diet, in particular soya consumption, and a reduced risk of VMS. Sustained oestrogen exposure has been associated with a higher risk of hormone-related cancers and thus high-fat and meat diets have been linked with an increased risk of these cancers. However, to better understand the mechanistic pathways involved and to make stronger conclusions for these relationships, further studies investigating the associations of dietary intakes and dietary patterns with menopause, presence of VMS and the risk of hormone-related cancers are required.

miR-452 Reverses Abnormal Glycosylation Modification of ERα and Estrogen Resistance in TNBC (Triple-Negative Breast Cancer) Through Targeting UGT1A1

“…Prospective studies suggest that plasma estrogen levels in postmenopausal women are significantly positively associated with the risk for BC while they are not receiving hormone replacement therapy (4,33,34). In addition, another large-scale prospective study confirms that endogenous estrogen is related to risk of BC in premenopausal women, and women undergoing estrogen replacement therapy after menopause and exogenous estrogen supplementation increase the risk for BC (35). On the one hand, estrogen acts as a cancer promoter by increasing mitosis of mammary duct epithelial cells.…”

Review of Mendelian Randomization Studies on Ovarian Cancer

“…Earlier menopause may be related to increased risk of OC. This theory is based on the gonadotropin hypothesis for pathogenesis of OC, which predicts that ovarian aging, accompanied by higher concentrations of follicle-stimulating and luteinizing hormones, increases the risk of OC ( 68 ). Previous MR analysis of individuals of European descent showed little evidence that late natural menopause is associated with risk of aggressive epithelial OC.…”

The Association Between Breast Cancer and Blood-Based Methylation of S100P and HYAL2 in the Chinese Population

“…In Chinese, the average age for BC diagnosis is only 45 years old (Li et al, 2016). The mean age of menopause in Asia is 48.8 years (Dunneram et al, 2019), and the perimenopausal period is normally 3-4 years before menopause which means 45-49 years. Thus, below 45 years could be considered as premenopausal, and above 45 years are mostly perimenopausal and postmenopausal.…”